These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37708849)

  • 1. Decoding the IBD paradox: A triadic interplay between REG3, enterococci, and NOD2.
    He X; Zhou H
    Cell Host Microbe; 2023 Sep; 31(9):1425-1427. PubMed ID: 37708849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial overproduction sustains intestinal inflammation by inhibiting Enterococcus colonization.
    Jang KK; Heaney T; London M; Ding Y; Putzel G; Yeung F; Ercelen D; Chen YH; Axelrad J; Gurunathan S; Zhou C; Podkowik M; Arguelles N; Srivastava A; Shopsin B; Torres VJ; Keestra-Gounder AM; Pironti A; Griffin ME; Hang HC; Cadwell K
    Cell Host Microbe; 2023 Sep; 31(9):1450-1468.e8. PubMed ID: 37652008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The inflammatory bowel disease (IBD) susceptibility genes NOD1 and NOD2 have conserved anti-bacterial roles in zebrafish.
    Oehlers SH; Flores MV; Hall CJ; Swift S; Crosier KE; Crosier PS
    Dis Model Mech; 2011 Nov; 4(6):832-41. PubMed ID: 21729873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial overproduction sustains intestinal inflammation by inhibiting
    Jang KK; Heaney T; London M; Ding Y; Yeung F; Ercelen D; Chen YH; Axelrad J; Gurunathan S; Marijke Keestra-Gounder A; Griffin ME; Hang HC; Cadwell K
    bioRxiv; 2023 Feb; ():. PubMed ID: 36778381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory bowel disease genetics: Nod2.
    Cho JH; Abraham C
    Annu Rev Med; 2007; 58():401-16. PubMed ID: 16987083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of NOD2 in intestinal immune response and microbiota modulation: A therapeutic target in inflammatory bowel disease.
    Liu Z; Zhang Y; Jin T; Yi C; Ocansey DKW; Mao F
    Int Immunopharmacol; 2022 Dec; 113(Pt B):109466. PubMed ID: 36435061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NOD2 mutations affect muramyl dipeptide stimulation of human B lymphocytes and interact with other IBD-associated genes.
    Lin Z; Hegarty JP; John G; Berg A; Wang Z; Sehgal R; Pastor DM; Wang Y; Harris LR; Poritz LS; Schreiber S; Koltun WA
    Dig Dis Sci; 2013 Sep; 58(9):2599-607. PubMed ID: 23709157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should family members of IBD patients be screened for CARD15/NOD2 mutations?
    Vermeire S; Van Assche G; Rutgeerts P
    Inflamm Bowel Dis; 2008 Oct; 14 Suppl 2():S190-1. PubMed ID: 18816704
    [No Abstract]   [Full Text] [Related]  

  • 9. Nucleotide-binding oligomerization domain (NOD) signaling defects and cell death susceptibility cannot be uncoupled in X-linked inhibitor of apoptosis (XIAP)-driven inflammatory disease.
    Chirieleison SM; Marsh RA; Kumar P; Rathkey JK; Dubyak GR; Abbott DW
    J Biol Chem; 2017 Jun; 292(23):9666-9679. PubMed ID: 28404814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between nucleotide oligomerisation domain two (Nod2) gene polymorphisms and canine inflammatory bowel disease.
    Kathrani A; Lee H; White C; Catchpole B; Murphy A; German A; Werling D; Allenspach K
    Vet Immunol Immunopathol; 2014 Sep; 161(1-2):32-41. PubMed ID: 25017709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic Polymorphisms of
    Mushtaq Hashim Al-Bderee N; Faaz Nassir Al-Saad N; Jawad Al-Imari M; Mudhaher Habbeb S; Mizal Azoz A
    Arch Razi Inst; 2023 Feb; 78(1):493-498. PubMed ID: 37312743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic and transcriptional analysis of inflammatory bowel disease-associated pathways in patients with GUCY2C-linked familial diarrhea.
    Tronstad RR; Polushina T; Brattbakk HR; Stansberg C; von Volkmann HL; Hanevik K; Ellinghaus E; Jørgensen SF; Ersland KM; Pham KD; Gilja OH; Hovdenak N; Hausken T; Vatn MH; Franke A; Knappskog PM; Le Hellard S; Karlsen TH; Fiskerstrand T
    Scand J Gastroenterol; 2018; 53(10-11):1264-1273. PubMed ID: 30353760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel NOD2 Mutation in Early-Onset Inflammatory Bowel Phenotype.
    Girardelli M; Loganes C; Pin A; Stacul E; Decleva E; Vozzi D; Baj G; De Giacomo C; Tommasini A; Bianco AM
    Inflamm Bowel Dis; 2018 May; 24(6):1204-1212. PubMed ID: 29697845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic association and phenotypic correlation of TLR4 but not NOD2 variants with Tunisian inflammatory bowel disease.
    Feki S; Bouzid D; Abida O; Chtourou L; Elloumi N; Toumi A; Hachicha H; Amouri A; Tahri N; Masmoudi H
    J Dig Dis; 2017 Nov; 18(11):625-633. PubMed ID: 29055077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Inflammatory bowel disease: IBD].
    Endo K; Shiga H; Kinouchi Y; Shimosegawa T
    Rinsho Byori; 2009 Jun; 57(6):527-32. PubMed ID: 19621784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunologic and genetic markers in patients with idiopathic ocular inflammation and a family history of inflammatory bowel disease.
    Abbasian J; Martin TM; Patel S; Tessler HH; Goldstein DA
    Am J Ophthalmol; 2012 Jul; 154(1):72-7. PubMed ID: 22464367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial effect of probiotics in IBD: are peptidogycan and NOD2 the molecular key effectors?
    Macho Fernandez E; Pot B; Grangette C
    Gut Microbes; 2011 Sep; 2(5):280-6. PubMed ID: 22067939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory bowel diseases phenotype, C. difficile and NOD2 genotype are associated with shifts in human ileum associated microbial composition.
    Li E; Hamm CM; Gulati AS; Sartor RB; Chen H; Wu X; Zhang T; Rohlf FJ; Zhu W; Gu C; Robertson CE; Pace NR; Boedeker EC; Harpaz N; Yuan J; Weinstock GM; Sodergren E; Frank DN
    PLoS One; 2012; 7(6):e26284. PubMed ID: 22719818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The innate immune system and inflammatory bowel disease.
    Davies JM; Abreu MT
    Scand J Gastroenterol; 2015 Jan; 50(1):24-33. PubMed ID: 25523553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insufficient evidence for association of NOD2/CARD15 or other inflammatory bowel disease-associated markers on GVHD incidence or other adverse outcomes in T-replete, unrelated donor transplantation.
    Nguyen Y; Al-Lehibi A; Gorbe E; Li E; Haagenson M; Wang T; Spellman S; Lee SJ; Davidson NO
    Blood; 2010 Apr; 115(17):3625-31. PubMed ID: 20177049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.